Stay updated on Canakinumab with Docetaxel in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.

Latest updates to the Canakinumab with Docetaxel in NSCLC: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous v3.4.2 in the page footer.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision: v3.4.1 is now shown in the page footer, replacing the previous v3.4.0. This is a minor platform update and does not alter the study record content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe history page now shows a glossary option, green highlights for additions and red highlights for deletions, and revision labels (e.g., Revision: v3.4.0) with corresponding removals (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedRevision: v3.3.4 was added, replacing v3.3.3. This appears to be a minor site update with no substantive changes to the trial information on the page.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded Revision: v3.3.3 to the Record History. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Canakinumab with Docetaxel in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.